What should myx do with the $120m+ Cashflow per year? I hope myx continues to be bold and invest in new drugs for the portfolio, naturally focusing on speciality brands first, and then other parts of the portfolio. I would even buy up more generic drugs, I think we are at the low for generics, and in a few years time, shareholders will get the benefit for buying in this depressed market. Although debt reduction is nice, it's not a big amount of debt, and interest rates aren't that high in this day and age. So focus should still be on growth
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.20 |
Change
-0.010(0.19%) |
Mkt cap ! $422.4M | |||
| Open | High | Low | Value | Volume |
| $5.22 | $5.25 | $5.07 | $964.0K | 186.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4000 | $5.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.20 | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |